D6.2 – Report mapping existing incentives for GPs
Most people never wonder how their family doctor is paid, yet the answer shapes the care they receive. Across Europe, governments and insurers have spent the past two decades adding extra payments on top of salaries and standard capitation, rewarding doctors who monitor patients with diabetes, who vaccinate more children, who work with nurses and specialists as a team, or who agree to practise in a remote village where no one else will. The intention is to nudge everyday clinical behaviour towards prevention, coordination and better management of long term conditions. Whether these payments actually deliver on that promise is a harder question, and answering it starts with knowing what has been tried and where.
This report provides that foundation. It reviews peer reviewed and grey literature to map the financial and non financial incentive schemes in use in primary care in nine EU countries, namely France, Italy, Germany, Estonia, Spain, the Netherlands, Sweden, Denmark and Portugal. Each country is presented in a standardised table covering the name of the scheme, whether it is monetary or not, its legal basis and origins, the behaviour it targets, how the reward is calculated, who receives the money and whether participation is voluntary. The mapping is preceded by a conceptual framework drawing on incentive theory and principal agent economics, and by a discussion of the design choices that matter most: the size of the payment, whether it goes to the individual doctor or to the team, the role of non financial rewards such as reduced paperwork and peer recognition, and the trade off between voluntary schemes with low uptake and mandatory ones that meet resistance. Three families of incentive emerge as dominant: pay for performance linked to quality indicators, enhanced capitation and bonus payments for chronic disease management, and targeted packages to recruit and retain doctors in underserved areas. The report also documents a clear institutional divide, with Germany, Denmark and the Netherlands operating uniform national frameworks while Italy and Spain leave design to regions, which makes comparison and evaluation considerably harder. On effectiveness the conclusion is cautious: gains tend to appear on the specific activities that are rewarded, while effects on hospital admissions, mortality and total costs remain limited, and risks of gaming and of selecting easier patients are real. The report therefore treats good design, strong governance and room for local adaptation as the conditions under which incentives are worth using at all.
What the deliverable contains:
- Country tables mapping the main primary care incentive schemes in nine EU member states, with legal basis, targets, reward mechanism, recipients and participation rules
- A conceptual overview of financial and non financial incentives, including principal agent theory and the interaction between intrinsic and extrinsic motivation
- A typology of the three most common incentive families in Europe: pay for performance, chronic care and coordination payments, and recruitment and retention schemes for underserved areas
- An assessment of the available evidence on effectiveness, including unintended consequences such as gaming, cherry picking and narrow focus on measured indicators
- Four practical design principles for policymakers, together with an infographic summarising the European landscape